A comparative study of CD34+ cells, CD34+ subsets, colony forming cells and cobblestone area forming cells in cord blood and bone marrow allografts

European Journal of Haematology

Volumn 62, Issue 3, 1999, Pages 174-183

  Theilgaard Mönch, Kim ^a,d   Raaschou Jensen, Klas ^b   Heilmann, Carsten ^c   Andersen, Helle ^b   Bock, Johannes ^d   Russel, Charlotte A ^a   Vindeløv, Lars ^a   Jacobsen, Niels ^a   Dickmeiss, Ebbe ^b  

^a FINSEN LABORATORY   (Denmark)

^b Department of Clinical Immunology   (Denmark)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Allogeneic transplantation; Bone marrow; CD34+ subsets; Cobblestone area forming cells; Cord blood; Hematopoietic progenitor cells

Indexed keywords

CD34 ANTIGEN;

ALLOGRAFT; ALLOTRANSPLANTATION; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL TRANSPLANTATION; COLONY FORMING UNIT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; HISTOCOMPATIBILITY; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; RECIPIENT; STEM CELL; UMBILICAL CORD BLOOD;

EID: 0033020819     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1999.tb01741.x     Document Type: Article

References (48)

1. BEATTY PG. Bone marrow transplantation for the treatment of hematological diseases: Status in 1994 (Meeting report). Exp Hematol 1995;23:277-288.
2. THOMAS ED. Marrow transplantation for malignant diseases (Meeting report). J Clin Oncol 1983;1:517-531.
3. BEATTY PG, DAHLBERG S, MICHELSON E, et al. Probability of finding HLA-matched unrelated marrow donors. Transplantation 1988;45:714-718.
4. RUUTU T, GOLDMAN JM. A Nordic registry for unrelated volunteer donors (Meeting report). Bone Marrow Transplantation 1990;5:273-277.
5. BEATTY PG, HANSEN JA, LONGTON GM, et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991;51:443-447.
6. GLUCKMAN E, ROCHA V, BOYER-CHAAMARD A, et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997;337:373-381.
7. KRUTZBERG J, LAUGHLIN M, GRAHAM ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-166.
8. WAGNER JE, ROSENTHAL J, SWEETMAN R, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment potential and acute graft-versus-host disease. Blood 1996;88:795-802.
9. CAIRO MS, WAGNER JE. Placental and/or umbilical cord blood: An alternative source of hematopoietic stem cells for transplantation. Blood 1997;90:4665-4678.
10. RUBINSTEIN P, DOBRILA L, ROSENFIELD RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated marrow reconstitution. Proc Natl Acad Sci USA 1995;92:10,119-10,122.
11. KÖGLER G, CALLEJAS J, HAKENBERG P, et al. Hematopoietic transplant potential of unrelated cord blood: Critical issues. J Hematother 1996;5:105-116.
12. BERTOLINI F, LAZZARI L, LAURI E, et al. Comparative study of different procedures for the collection and banking of umbilical cord blood. J Hematother 1995;4:29-36.
13. SIENA S, BREGNI M, BRANDO B, et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991;77:400-409.
14. BROXMEYER HE, DOUGLAS GW, HANGOC G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989;86:3828-3832.
15. MA DF, VARGA DE, BIGGS JC. Donor marrow progenitors (CFU-Mix, BFU-E and CFU-GM) and haematopoietic engraftment following HLA matched sibling bone marrow transplantation. Leukemia Res 1987;11:141-147.
16. KÖRBLING M, PRZEPIORKA D, HUH YO, et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 1995;85:1659-1665.
17. + subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both. Exp Hematol 1996;24:1460-1468.
18. + cells and subpopulations from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation. Clin Immunol Immunopathol 1994;70:10-18.
19. - cells in cord blood and bone marrow. Blood 1995;86:3745-3753.
20. MOORE MAS, METCALF D. Ontogeny of the hematopoietic system: Yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo. Br J Heamatol 1970;18:279-296.
21. LANSDORP PM, DRAGOWSKA W, MAYANI H. Ontogeny related changes in proliferative potential of human hematopoietic cells. J Exp Med 1993;178:787-791.
22. HARRISON DE, ASTLE CM, STONE M. Numbers and functions of transplantable primitive immunohematopoietic stem cells. J Immunol 1989;142:3833-3840.
23. + hematopoietic stem cells. Blood 1994;83:3758-3779.
24. ZIJLMANS JM, VISSER JW, KLEIVERDA K, KLUIN PM, WILLEMZE R, FIBBE WE. Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow repopulating ability. Proc Natl Acad Sci USA 1995;92:8901-8905.
25. - progenitor cells. Blood 1991;77:1218-1227.
26. BHATIA M, WANG JCY, KAPP U, BONNET D, DICK JE. Purification of primitive human hematopietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 1997;94:5320-5325.
27. TRAYCOFF CM, ABBOUD MR, LAVER J, et al. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood progenitor cells. Exp Hematol 1994;22:215-222.
28. - hematopoietic stem cells. Blood 1994;83:1515-1526.
29. + bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis. Blood Cells 1991;17:287-295.
30. SUTHERLAND HJ, LANSDORP PM, HENKELMAN DH, EAVES AC, EAVES CJ. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci 1990;87:3584-3588.
31. BREEMS DA, BLOKLAND EAW, NEBEN S, PLOEMACHER RE. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia 1994;8:1095-1095.
32. + cells in peripheral and cord blood by flow cytometry. Exp Hematol 1994;22:1003-1010.
33. + peripheral blood stem cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1994;84:2795-2801.
34. SUTHERLAND HJ, EAVES AC, EAVES CJ. Quantitative assays for human hematopoietic progenitor cells In: GEE AP, ed. Bone Marrow Processing and Purging. Boca Raton: CRC Press Inc., 1991:155-171.
35. TASWELL C. Limiting dilution assays for the determination of immunocompetent cell frequencies, I. data analysis. J Immunol 1981;126:1614-1619.
36. FAZEKAS DE St. Groth S. The evaluation of limiting dilution assays. J Immunol Meth 1982;49:R11-R23.
37. + cells purified after cryopreservation. Exp Hematol 1995;23:1589-1594.
38. CRAIG W, KAY R, CUTLER RL, LANSDORP PM. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 1995;177:1331-1342.
39. PETTENGELI R, LUFT T, HENSCHLER R, et al. Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human marrow, umbilical cord blood, and blood stem cells. Blood 1994;84:3653-3661.
40. ADEMOKIN JA, CHAPMAN C, DUNN D, et al. Umbilical cord blood collection and separation for hematopoietic progenitor cell banking. Bone Marrow Transpl 1997;19:1023-1028.
41. HOWS J, BRADLEY BA, MARSH JCW, et al. Growth of human umbilical-cord blood in long-term hematopoietic cultures. Lancet 1992;340:73-76.
42. BROXMEYER HE, COOPER S. High-efficiency recovery of immature haematopoietic progenitor cells with extensive proliferative capacity from human cord blood cryopreserved for 10 yr. Clin Exp Immunol 1997;107(suppl. 1):45-53.
43. QUEROL S, GBARRÓ M, AMAT L, et al. The placental blood program of Barcelona Cord Blood Bank. Report activity at February. J Hematother 1976:384 (abstr).
44. ALMICI C, CARLO-STELLA C, WAGNER JE, et al. Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation. Bone Marrow Transplantation 1997;19:1079-1084.
45. HARADA M, YOSHIDA T, ISHINO C, et al. Hematological recovery following autologous and allogeneic bone marrow transplantation. Exp Hematol 1983;11:841-848.
46. ANASETTI C, AMOS D, BEATTY PG, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989;320:197-204.
47. LAPORTE J-P, GORIN N-C, RUBINSTEIN P, et al. Transplantation from an unrelated donor in adult with chronic myeloid leukemia. N Eng J Med 1996;335:167-170.
48. SCHMITZ N, DREGER P, SUTTROP M, et al. Primary transplantation of allegenic peripheral blood progenitor cells mobilized by Filgastrim (granulocyte colony-stimulating factor). Blood 1995;85:1666-1672.